All hedge funds or institutions that manage over $100M are required by the SEC to file quarterly reports on their holdings.
These reports are called 13F reports. However, the filings are required
the following quarter
from the reporting period,
which means that by the time the filing is made (and we see them), the information could be five months old.
For funds
with long term positions that make few trades, the holdings might closely resemble their current holdings, even after several months. However, for funds that have high turnover,
the holdings data we see might differ significantly from their current holdings. Institutions are required to report CALL and PUT options, and those positions
are identified in the table. However, they are not required to report short positions.
Click the link icon to see the full transaction history.
Upgrade
to unlock premium data and export to Excel
.
Security |
Imputed Share Price |
Prev Shares |
Current Shares |
Change (Percent) |
Prev Value (USD x1000) |
Current Value (USD x1000) |
Change (Percent) |
LJPC / La Jolla Pharmaceutical Co.
|
|
|
|
|
|
|
|
US62857M1053 / MyoKardia, Inc.
|
|
|
|
|
|
|
|
YMTX / Yumanity Therapeutics Inc
|
|
|
|
|
|
|
|
RMED / Catheter Precision Inc.
|
|
|
|
|
|
|
|
PACB / Pacific Biosciences of California, Inc.
|
|
|
|
|
|
|
|
928551AB6 / Vivus Inc Bond
|
|
|
|
|
|
|
|
MOTS / Motus GI Holdings, Inc.
|
|
|
|
|
|
|
|
NVTR / Nuvectra Corporation
|
|
|
|
|
|
|
|
STIM / Neuronetics, Inc.
|
|
|
|
|
|
|
|
PTE / PolarityTE Inc
|
|
|
|
|
|
|
|
ECOR / electroCore, Inc.
|
|
|
|
|
|
|
|
ELDN / Eledon Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
US00448Q2012 / Achillion Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
928551AA8 / VIVUS, Inc. Bond
|
|
|
|
|
|
|
|
CORI / Corium International, Inc.
|
|
|
|
|
|
|
|
QGEN / Qiagen N.V.
|
|
|
|
|
|
|
|
CDNA / CareDx, Inc
|
|
|
|
|
|
|
|
ODT / Odonate Therapeutics Inc
|
|
|
|
|
|
|
|
ABUS / Arbutus Biopharma Corporation
|
|
|
|
|
|
|
|
MRKR / Marker Therapeutics, Inc.
|
|
|
|
|
|
|
|
US74257L1089 / Principia Biopharma Inc.
|
|
|
|
|
|
|
|
RMD / ResMed Inc.
|
|
|
|
|
|
|
|
LIVN / LivaNova PLC
|
|
|
|
|
|
|
|
ADVM / Adverum Biotechnologies, Inc.
|
|
|
|
|
|
|
|
VIVE / Viveve Medical, Inc.
|
|
|
|
|
|
|
|
BMY / Bristol-Myers Squibb Company
|
|
|
|
|
|
|
|
PRQR / ProQR Therapeutics N.V.
|
|
|
|
|
|
|
|
SRPT / Sarepta Therapeutics, Inc.
|
|
|
|
|
|
|
|
NVAX / Novavax, Inc.
|
|
|
|
|
|
|
|
ARWR / Arrowhead Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
BLCM / Bellicum Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
DRNA / Dicerna Pharmaceuticals Inc
|
|
|
|
|
|
|
|
FIXX / Homology Medicines, Inc.
|
|
|
|
|
|
|
|
AGEN / Agenus Inc.
|
|
|
|
|
|
|
|
ESTA / Establishment Labs Holdings Inc.
|
|
|
|
|
|
|
|
RGNX / REGENXBIO Inc.
|
|
|
|
|
|
|
|
SLDB / Solid Biosciences Inc.
|
|
|
|
|
|
|
|
MASI / Masimo Corporation
|
|
|
|
|
|
|
|
ALNY / Alnylam Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
ILMN / Illumina, Inc.
|
|
|
|
|
|
|
|
VRAY / ViewRay Inc.
|
|
|
|
|
|
|
|
VCEL / Vericel Corporation
|
|
|
|
|
|
|
|
VKTX / Viking Therapeutics, Inc.
|
|
|
|
|
|
|
|
APYX / Apyx Medical Corporation
|
|
|
|
|
|
|
|
QURE / uniQure N.V.
|
|
|
|
|
|
|
|
PTCT / PTC Therapeutics, Inc.
|
|
|
|
|
|
|
|
ARGX / argenx SE - Depositary Receipt (Common Stock)
|
|
|
|
|
|
|
|
RCKT / Rocket Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|